Skip To Main Content
Lilly
Menu closed
Lilly
  • Account Login / Register
  • Medical Home
  • Medical Education
      • All Therapeutic Areas
        • Alopecia Areata
        • Atopic Dermatitis
        • Dermatology
        • Psoriasis
        • Diabetes
        • Hypoglycemia
        • Inflammatory Bowel Disease
        • Crohn's Disease
        • Ulcerative Colitis
        • Migraine
        • Alzheimer's Disease
        • Cognitive Health
        • Obesity
        • Obstructive Sleep Apnea
        • Breast Cancer - Early
        • Breast Cancer - Metastatic
        • Hematological Malignancy
        • Non-Small Cell Lung Cancer
        • Oncology Precision Medicine
        • Thyroid Cancer
        • Axial Spondyloarthritis
        • Psoriatic Arthritis
        • Resources
      • All Therapeutic Areas
        • Alopecia Areata
        • Atopic Dermatitis
        • Psoriasis
        • Diabetes
        • Hypoglycemia
        • Inflammatory Bowel Disease
        • Cluster Headache
        • Migraine
        • Alzheimer's Disease
        • Cognitive Health
        • Obesity
        • Obstructive Sleep Apnea
        • Breast Cancer - Metastatic
        • Gastrointestinal Cancer
        • Hematological Malignancy
        • Oncology
        • Osteoporosis
        • Rheumatoid Arthritis
        • Resources
  • Independent Medical Education
    • Cardiovascular
      • Alopecia Areata
      • Atopic Dermatitis
      • Psoriasis
      • Diabetes
      • Crohn's Disease
      • Ulcerative Colitis
      • Migraine
      • Alzheimer's Disease
      • Obesity
      • Obstructive Sleep Apnea
      • Breast Cancer
      • Gastrointestinal Cancer
      • Hematological Malignancy
      • Non-Small Cell Lung Cancer
      • Oncology
      • Oncology Precision Medicine
      • Prostate Cancer
      • Axial Spondyloarthritis
      • Psoriatic Arthritis
  • Chat Contact Us
Lilly

You are now leaving the Lilly Medical Education website

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to Lilly Medical Education.

The Communicating Needs and Features of IBD Experiences (CONFIDE) Study

Loading icon

Methods

Crohn’s Disease

Ulcerative Colitis

Explore the Impact of UC Symptoms: Insights from the CONFIDE Study

Discover valuable insights into the impact of ulcerative colitis (UC) symptoms on patients’ lives through the Communicating Needs and Features of IBD Experiences (CONFIDE) Study. This research initiative delves into the experiences of patients with moderate-to-severe UC, shedding light on critical aspects such as:

  1. Patient Demographics and Characteristics: Understand the baseline demographics for the United States (US) and European (EU) patients that participated in the study
  2. Key Symptoms: See data on the prevalence of symptoms, including diarrhea, bowel urgency, and increased stool frequency
  3. Diapers/Pads/Protection Usage: Learn about the use of protective measures by patients due to fear of bowel urgency-related accidents
  4. Impact on Social Activities and Sexual Function: Explore how UC symptoms influence patients’ participation in social events, work, school, sports, and sexual activity
  5. Healthcare Provider - Patient Communication: Discover how healthcare providers (HCPs) view symptoms of moderate-to-severe UC and explore communication gaps between HCPs and patients

By bridging the gap between patient experiences and healthcare professionals, the CONFIDE Study aims to enhance patient care and communication.

1. Patient Demographics and Characteristics1

There were 200 patients from the US and 556 European patients that met the eligibility requirements and completed the survey from July to September 2021. The average age of these patients was roughly 40 years (mean age 40.4 and 38.9 for US and European patients) and most participants were male (61.5% and 57.4% for US and EU patients). The most common UC treatments received by both US and European patients included anti-TNF therapies (46.5% and 54.1%) and corticosteroids (40.5% and 62.4%).Both patient groups were similar in that the average time since UC diagnosis was about 8 years (7.9 mean time in both US and European patients).

Demographic data of US and EU patients with moderate-to-severe UC participating in CONFIDE study.
chevron-filled-down View description

2. Key findings from the CONFIDE US and EU dataset1

To assess the burden of UC-related symptoms, patients were asked a series of questions that involved selecting from a list of 30 symptoms. Diarrhea, bowel urgency, and bowel urgency-related accidents were the top 3 most impactful symptoms whereas diarrhea, bowel urgency, and increased stool frequency were the most frequently reported symptoms experienced by patients with moderate-to-severe UC in the US and EU.1


Most Common and Impactful Symptoms Reported by Patients
Most commonly reported symptoms and symptoms with the greatest impact reported by patients with ulcerative colitis
chevron-filled-down View description

3. Use of diapers, pads or other protection in the last three months due to fear/anticipation of bowel urgency-related accident2

Patients with UC were asked if they had to wear a diaper/pad/other protection due to fear or anticipation of fecal urgency incontinence (i.e. bowel urgency-related accident) in the past 3 months. The majority of patients in both the US and Europe reported wearing diaper/pad/protection at least once a month in the past 3 months. This finding was also consistently reported in patients that received advanced therapies.2


Frequency of symptoms/impact in the past 3 months in patients with UC
Frequency of diapers, pads or other protection use in patients with UC
chevron-filled-down View description
Frequency of symptoms/impact among patients receiving advanced therapiesa in the past 3 months in patients with UC
Frequency of diapers, pads or other protection use in patients with UC receiving advanced therapies Frequency of diapers, pads or other protection use in patients with UC receiving advanced therapies
chevron-filled-down View description

4. Impact of UC Symptoms on work/school life, social life, and ability to participate in sports/physical exercise3

Patients were asked if they had previously declined participating in work/school, social events, or sports/physical exercise within the last 3 months. Patients then selected from a list of reasons that included common UC symptoms why they had declined participation. Bowel urgency and fear of bowel urgency-related accidents were among some of the top reasons listed as to why they had declined participating in daily activities. These findings were consistent in both the US and European patients.3


Majority of Patients Surveyed Reported That They Needed to Decline Participation In Daily Activities Because of Their UC-Related Symptoms
Majority of patients with UC reported declining participation in daily activities
chevron-filled-down View description

Patients avoiding or decreasing sexual activity due to UC4

Patients were asked if within the last 3 months they had avoided or decreased sexual activity because of UC. More than half of the patients with UC surveyed opted to either abstain from or reduce sexual activity.4


Patients Avoiding or Decreasing Sexual Activity Due to UC

63% of US patients and 53% of EU patients with UC avoided or decreased sexual activity

Reasons US and EU patients avoided or decreased sexual activity in the last 3 months4

Among patients with moderate-to-severe UC who decreased or avoided sexual activity in the last 3 months, fear of bowel urgency was ranked as the top reason. Additional reasons included decreased sexual desire, fear of bowel urgency-related accidents, fear of bowel movement accidents, and fear of fecal seepage.4


5. Explore HCP-Perceived UC Symptoms and HCP-Patient Communication Gaps: Insights from the CONFIDE Study

The Communicating Needs and Features of IBD Experiences (CONFIDE) Study provides valuable insights into how healthcare professionals (HCPs) perceive symptoms related to moderate-to-severe ulcerative colitis (UC). This study sheds light on critical aspects

Surveyed HCPs were asked to rank the top UC symptoms most reported by their patients. Despite being ranked second among patients with UC, bowel urgency was not perceived by HCPs to be among the most common symptoms reported by patients.1

HCP-perceived most common UC symptoms reported by patients HCP-perceived most common UC symptoms reported by patients
chevron-filled-down View description

Even though bowel urgency was included as one of the top 3 symptoms with the greatest impact on patients, healthcare providers did not rank it in the top 3 symptoms that impact treatment decisions. The top ranked symptoms that greatly impacted the treatment decisions of HCPs included blood in stool, diarrhea, and increased stool frequency.1

Top symptoms with greatest impact on HCPs’ treatment decisions and HCP perceived greatest impact on patients with moderate-tosevere UC
chevron-filled-down View description

Communication Gaps Between HCPs and Patients1

Over 30% of US patients and 40% of EU patients surveyed reported that they do not feel comfortable discussing bowel urgency with their healthcare provider. The most common reason cited was feeling embarrassed to do so. Other reasons patients ranked included that there was not enough time in the appointment, that they would be wasting the HCP’s time, and that their providers cannot help them. Roughly three-quarters of patients in both the US and Europe said that they would like to discuss this symptom more frequently with their providers. Healthcare providers were asked if they proactively discuss bowel urgency during a routine appointment. The top symptoms proactively discussed by HCPs during routine appointments were blood in stool, diarrhea, and increased stool frequency. Among providers who do not proactively discuss bowel urgency, the top reason cited was that patients should bring this up during the appointment if it is an issue.1
Reasons patients with UC reported feeling uncomfortable discussing bowel urgency and reasons HCPs did not proactively discuss bowel urgency Reasons patients with UC reported feeling uncomfortable discussing bowel urgency and reasons HCPs did not proactively discuss bowel urgency
chevron-filled-down View description

Related Resources

Downloadable PDFs

Download PDF Medical Answer PDF Document Created with Sketch. Communicating Needs and Features of IBD Experiences (CONFIDE) Study: Key results for US patients with ulcerative colitis

This infographic summarizes the key results of the CONFIDE study for patients with moderate-to-severe ulcerative colitis in the United States.

EU=European; HCP=Healthcare Providers; IBD=Inflammatory Bowel Disease; TNF=Tumor Necrosis Factor; UC=Ulcerative Colitis; US=United States

References

  1. Travis S, Potts Bleakman A, Dubinsky MC, et al. The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-toSevere Ulcerative Colitis. Inflamm Bowel Dis. 2023; doi: 10.1093/ibd/izad142 (Ahead of print).
  2. Schreiber S, Gibble TH, Dubinsky MC, et al. S855 Communicating Needs and Features of IBD Experiences (CONFIDE) Survey: Burden and Impact of Bowel Urgency is Similar in Patients With Moderate-to-Severe Crohn’s Disease and Ulcerative Colitis. Am J Gastroenterol. 2023;118(10S): S633-S634.
  3. Schreiber S, Gibble TH, Dubinsky MC, et al. Communicating Needs and Features of IBD Experiences (CONFIDE) Survey: Burden and Impact of Bowel Urgency is Similar in Patients with Moderate-to-Severe Crohn’s Disease and Ulcerative Colitis. Poster presented at American College of Gastroenterology; 20 25 October 2023; Vancouver, Canada. Poster P-0678.
  4. Travis S, Potts Bleakman A, Dubinsky M, et al. United States and European patient perspectives on the impact of moderate-tosevere Ulcerative Colitis on sexual activity: Communicating Needs and Features of IBD Experiences (CONFIDE) survey. Poster presented at European Crohns and Colitis Organization - 2023 Congress; 1-4 March 2023; Copenhagen, Denmark. Poster P507.

VV-MED-134811

Please rate your satisfaction with the content on the following statements:

Very Dissatisfied

Dissatisfied

Neutral

Satisfied

Very Satisfied

Credibility of information
Credibility of information
Relevance of the information to my needs
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice
Confidence to implement the learnings in my clinical practice

Please rate your satisfaction with the content on the following statements:

Credibility of information
Credibility of information
Very Satisfied
Very Dissatisfied
Relevance of the information to my needs
Relevance of the information to my needs
Very Satisfied
Very Dissatisfied
Confidence to implement the learnings in my clinical practice
Confidence to implement the learnings in my clinical practice
Very Satisfied
Very Dissatisfied
  • Copyright
  • Terms of Use
  • Privacy Statement
  • Consumer Health Privacy Notice
  • Accessibility Statement
  • Sitemap

To speak to customer support:
Call (XXX) XXX-XXXX

This site is intended for US Healthcare Professionals only.

4.4.53 05/2025 | GLOOTH00001 04/2015 | © Lilly USA, LLC 2025. All rights reserved.

Product names listed above are trademarks or registered trademarks owned by or licensed to Eli Lilly and Company, its subsidiaries, or affiliates

California Consumer Privacy Act (CCPA) Opt-Out Icon Your Privacy Choices
Cookie Settings
Facebook X LinkedIn
Lilly